Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 20 | 22 | +2 |
| Shares | 1.27M | 1.92M | +652.4K (+51.4%) |
| Value | $2.96M | $3.38M | +$422.9K (+14.3%) |
New holders (5)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Minot Wealth Management LLC | 50,000 | $88.0K | 0.02% |
| Group One Trading, L.P. | 27,066 | $48.0K | 0.00% |
| XTX Topco Ltd | 11,867 | $21.0K | 0.01% |
| Simplex Trading, LLC | 6,643 | $11.0K | 0.00% |
| Morgan Stanley | 1,275 | $2.00K | 0.00% |
Sold out (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Jane Street Group, LLC | 39,680 | $92.0K |
| Virtu Financial LLC | 12,200 | $28.0K |
| Citigroup Inc | 750 | $2.00K |